Drug maker Daiichi Sankyo Co. said Friday its Chinese unit Daiichi Sankyo (China) Holdings Co. has agreed to buy out Shanghai Xinshengyuan Pharmaceutical Group Medicine & Chemical Reagents Sales Co., a marketing company, from Shanghai Xinshengyuan Pharmaceutical (Group) Co.
The acquisition will open the path for Daiichi Sankyo to import and market the products of other drugmakers, including its India-based group company Ranbaxy Laboratories Ltd., in China, it added.